{"type":"rich","provider_url":"https://hatena.blog","blog_title":"\u30ea\u30f3\u30b3's \u30b8\u30e3\u30fc\u30ca\u30eb","height":"190","provider_name":"Hatena Blog","width":"100%","title":"\u9ad8\u8840\u5727\u306e\u6709\u540d\u8ad6\u6587\u3082\u308d\u3082\u308d\u30fc1(\u300cSHEP\u300d\u300cINSIGHT\u300d\u300cPROGURESS\u300d)","version":"1.0","author_url":"https://blog.hatena.ne.jp/gacharinco/","categories":["\u9ad8\u8840\u5727"],"url":"https://www.rincos-journal.com/entry/2019/03/09/145329","image_url":null,"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fwww.rincos-journal.com%2Fentry%2F2019%2F03%2F09%2F145329\" title=\"\u9ad8\u8840\u5727\u306e\u6709\u540d\u8ad6\u6587\u3082\u308d\u3082\u308d\u30fc1(\u300cSHEP\u300d\u300cINSIGHT\u300d\u300cPROGURESS\u300d) - \u30ea\u30f3\u30b3&#39;s \u30b8\u30e3\u30fc\u30ca\u30eb\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_name":"gacharinco","blog_url":"https://www.rincos-journal.com/","description":"\u524d\u56de\u7d39\u4ecb\u3057\u305f\u8ad6\u658718\u4ef6\u3092\u3001\u3053\u308c\u304b\u30893\u3064\u305a\u3064\u5e74\u4ee3\u9806\u306b\u7d39\u4ecb\u3057\u3066\u3044\u304d\u307e\u3059\u3002 \u307e\u305a\u4eca\u56de\u306f\u300cSHEP\u300d\u300cINSIGHT\u300d\u300cPROGURESS\u300d\u3092\u53d6\u308a\u4e0a\u3052\u307e\u3059\u3002 \u4e00\u3064\u76ee\u306f\u300cSHEP\u300d\u8a66\u9a13\u3002 Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research G\u2026","published":"2019-03-09 14:53:29"}